 |
Articles: M&A/Partnerships |
Prior Articles
Merck Prices $4.25 Billion Debt Offering
Merck & Co., 06/23/09
Free full text
WebMD, HLTH Again Try to Merge
HealthDataManagement, 06/23/09 Arbitration Panel Decision Received in Decision-Making Disagreement Between Genentech and Biogen Idec
Genentech, 06/22/09
Free full text
PhRMA Statement on the Health Care Reform Agreement
PhRMA, 06/22/09
Free full text
Maximizing the use of Project Bioshield contracting opportunities
Drug Development Research, 06/19/09 Strativa's development partner, bioalliance pharma, submits loramyc nda
Par Pharmaceutical, 06/17/09 GSK announces a strategic alliance with Dr. Reddys to further accelerate sales growth in emerging markets
GlaxoSmithKline, 06/16/09
Free full text
Novation and Cancer Therapeutics establish collaboration for the discovery and development of new cancer therapies
b3c newswire, 06/16/09 Bayer HealthCare and Genzyme Finalize Strategic Alliance Agreement
BayNews International, 06/11/09
Free full text
Taro and Quinnova Announce Agreement to Co-Promote Neosalus and Cleanse and Treat in the United States
Taro Pharmaceuticals USA, 06/11/09
Free full text
New graduate degree offered focusing on health care quality
National Committee for Quality Assurance (NCQA), 06/11/09 Amarna Therapeutics B.V. and TNO announce SVac research and development partnership
b3c newswire, 06/10/09 Angiotech pharmaceuticals announces fda 510 clearance of the option inferior vena cava filter
Angiotech Pharmaceuticals, 06/09/09
Free full text
Novartis announces typhoid vaccine research program in partnership with the Wellcome Trust
Novartis, 06/05/09
Free full text
AstraZeneca and Abbott extend relationship to include co-promotion of TRILIPIX (fenofibric acid)
AstraZeneca, 06/05/09
Free full text
Abbott and AstraZeneca Extend Relationship to Include Co-promotion of TRILIPIX (fenofibric acid)
Abbott, 06/05/09 GSK Signs Deal with Concert Pharma to the Tune of $1 Billion
PharmExec, 06/04/09 Angiotech enters license, distribution and supply agreements for fibrin and thrombin technologies with
haemacure corporation
Angiotech Pharmaceuticals, 06/04/09
Free full text
AstraZeneca and Merck and Co., Inc. Form Pioneering Collaboration to Investigate Novel Combination Anticancer Regimen
Merck & Co., 06/02/09
Free full text
AstraZeneca and Merck form collaboration
PharmExec, 06/02/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
